Roanna Ruiz
Stock Analyst at Leerink Partners
(0.95)
# 3,989
Out of 5,090 analysts
458
Total ratings
44.7%
Success rate
-1.2%
Average return
Main Sectors:
Stocks Rated by Roanna Ruiz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRMD CorMedix | Reiterated: Buy | $15 → $16 | $5.70 | +180.95% | 12 | Oct 20, 2026 | |
| UTHR United Therapeutics | Rated: Buy | $685 → $725 | $598.72 | +21.09% | 29 | Oct 20, 2026 | |
| VIR Vir Biotechnology | Reiterated: Buy | $19 → $17 | $11.30 | +50.44% | 35 | Sep 29, 2026 | |
| MNKD MannKind | Reiterated: Buy | $7 | $3.50 | +100.00% | 2 | Sep 10, 2026 | |
| XERS Xeris Biopharma Holdings | Reiterated: Buy | $9 → $16 | $10.71 | +49.39% | 36 | Sep 10, 2026 | |
| SPRY ARS Pharmaceuticals | Reiterated: Buy | $28 → $15 | $3.38 | +343.79% | 28 | Sep 8, 2026 | |
| AKBA Akebia Therapeutics | Downgraded: Hold | $7 → $1 | $0.7065 | +41.54% | 7 | Aug 7, 2026 | |
| LNTH Lantheus Holdings | Downgraded: Hold | $99 → $103 | $100.46 | +2.03% | 54 | Aug 3, 2026 | |
| KARD Kardigan | Initiated Coverage: Buy | $37 | $14.13 | +161.85% | 1 | Jul 13, 2026 | |
| AQST Aquestive Therapeutics | Reiterated: Buy | $9 | $3.89 | +131.36% | 24 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $6 | $0.7687 | +680.54% | 3 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $62.99 | - | 30 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $13.56 | +17.99% | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $9 | $10.71 | n/a | 37 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.00 → $2.00 | $0.98 | n/a | 8 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $1.42 | n/a | 17 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $107 → $44 | $20.06 | n/a | 27 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $11 | $3.03 | n/a | 11 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $12.11 | n/a | 30 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $174.87 | n/a | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $4 | $4.11 | n/a | 23 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 | $4.80 | n/a | 22 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 | $81.12 | n/a | 6 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 | $0.000001 | n/a | 13 | Dec 20, 2022 |
CorMedix
Oct 20, 2026
Reiterated: Buy
Price Target: $15 → $16
Current: $5.70
Upside: +180.95%
United Therapeutics
Oct 20, 2026
Rated: Buy
Price Target: $685 → $725
Current: $598.72
Upside: +21.09%
Vir Biotechnology
Sep 29, 2026
Reiterated: Buy
Price Target: $19 → $17
Current: $11.30
Upside: +50.44%
MannKind
Sep 10, 2026
Reiterated: Buy
Price Target: $7
Current: $3.50
Upside: +100.00%
Xeris Biopharma Holdings
Sep 10, 2026
Reiterated: Buy
Price Target: $9 → $16
Current: $10.71
Upside: +49.39%
ARS Pharmaceuticals
Sep 8, 2026
Reiterated: Buy
Price Target: $28 → $15
Current: $3.38
Upside: +343.79%
Akebia Therapeutics
Aug 7, 2026
Downgraded: Hold
Price Target: $7 → $1
Current: $0.7065
Upside: +41.54%
Lantheus Holdings
Aug 3, 2026
Downgraded: Hold
Price Target: $99 → $103
Current: $100.46
Upside: +2.03%
Kardigan
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $37
Current: $14.13
Upside: +161.85%
Aquestive Therapeutics
May 15, 2026
Reiterated: Buy
Price Target: $9
Current: $3.89
Upside: +131.36%
May 15, 2026
Reiterated: Buy
Price Target: $5 → $6
Current: $0.7687
Upside: +680.54%
Jan 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $62.99
Upside: -
Nov 18, 2025
Reiterated: Buy
Price Target: $16
Current: $13.56
Upside: +17.99%
Oct 1, 2025
Reiterated: Hold
Price Target: $7 → $9
Current: $10.71
Upside: n/a
Aug 25, 2025
Reiterated: Hold
Price Target: $1.00 → $2.00
Current: $0.98
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $1
Current: $1.42
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $107 → $44
Current: $20.06
Upside: n/a
Aug 5, 2025
Reiterated: Buy
Price Target: $10 → $11
Current: $3.03
Upside: n/a
Jul 31, 2025
Reiterated: Hold
Price Target: $10
Current: $12.11
Upside: n/a
Mar 6, 2025
Reiterated: Buy
Price Target: n/a
Current: $174.87
Upside: n/a
May 14, 2024
Reiterated: Hold
Price Target: $5 → $4
Current: $4.11
Upside: n/a
May 7, 2024
Reiterated: Hold
Price Target: $25
Current: $4.80
Upside: n/a
Jan 22, 2024
Reiterated: Hold
Price Target: $23
Current: $81.12
Upside: n/a
Dec 20, 2022
Reiterated: Hold
Price Target: $80
Current: $0.000001
Upside: n/a